Medikaloka Hermina PT (HEAL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medikaloka Hermina PT (HEAL) has a cash flow conversion efficiency ratio of 0.032x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp225.37 Billion ≈ $13.21 Million USD) by net assets (Rp7.01 Trillion ≈ $410.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see HEAL market cap overview for the company's overall valuation and market capitalisation.
Medikaloka Hermina PT - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Medikaloka Hermina PT's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Medikaloka Hermina PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medikaloka Hermina PT ranked by their cash flow conversion efficiency. Explore Medikaloka Hermina PT (HEAL) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Archean Chemical Industries Limited
NSE:ACI
|
0.018x |
|
Wuxi Xuelang Environmental Technology Co Ltd
SHE:300385
|
0.201x |
|
SIMILARWEB LTD IS-01
F:63X
|
0.395x |
|
CK Power Public Company Limited
BK:CKP
|
0.017x |
|
Stadio Holdings Ltd
JSE:SDO
|
0.151x |
|
OneSpan Inc
NASDAQ:OSPN
|
0.000x |
|
Aris Water Solutions Inc
NYSE:ARIS
|
0.093x |
|
Ningbo Sinyuan ZM Technology Co. Ltd. A
SHE:301398
|
N/A |
Annual Cash Flow Conversion Efficiency for Medikaloka Hermina PT (2015–2024)
The table below shows the annual cash flow conversion efficiency of Medikaloka Hermina PT from 2015 to 2024. View Medikaloka Hermina PT share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp5.87 Trillion ≈ $343.74 Million |
Rp1.14 Trillion ≈ $66.66 Million |
0.194x | -23.61% |
| 2023-12-31 | Rp5.20 Trillion ≈ $304.60 Million |
Rp1.32 Trillion ≈ $77.33 Million |
0.254x | +136.20% |
| 2022-12-31 | Rp4.69 Trillion ≈ $274.55 Million |
Rp503.58 Billion ≈ $29.51 Million |
0.107x | -74.60% |
| 2021-12-31 | Rp4.39 Trillion ≈ $257.02 Million |
Rp1.86 Trillion ≈ $108.77 Million |
0.423x | +27.07% |
| 2020-12-31 | Rp3.38 Trillion ≈ $198.18 Million |
Rp1.13 Trillion ≈ $66.01 Million |
0.333x | +60.80% |
| 2019-12-31 | Rp2.76 Trillion ≈ $161.98 Million |
Rp572.58 Billion ≈ $33.55 Million |
0.207x | +103.10% |
| 2018-12-31 | Rp2.37 Trillion ≈ $138.86 Million |
Rp241.67 Billion ≈ $14.16 Million |
0.102x | -79.03% |
| 2017-12-31 | Rp956.53 Billion ≈ $56.05 Million |
Rp465.08 Billion ≈ $27.25 Million |
0.486x | +68.84% |
| 2016-12-31 | Rp1.26 Trillion ≈ $73.83 Million |
Rp362.85 Billion ≈ $21.26 Million |
0.288x | +7.84% |
| 2015-12-31 | Rp957.59 Billion ≈ $56.11 Million |
Rp255.71 Billion ≈ $14.98 Million |
0.267x | -- |
About Medikaloka Hermina PT
PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, orthopedic surgery, plastic and reconstructive surgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, nuclear medici… Read more